A dramatic late-gestation increase in fetal plasma cortisol concentrations is critical for the timing of parturition in the sheep. This increase appears to depend upon an intact hypothalamo-pituitary unit and is characterised by increasing responsiveness of the fetal adrenal gland to ACTH. ACTH has been postulated as the critical determinant of the late-gestation cortisol increase; however, recent evidence has suggested that other factors, including the ACTH precursor, pro-opiomelanocortin, may also be involved. To further define the role of ACTH in determining the timing of parturition and the responsiveness of the fetal adrenal gland, intact (INT/ACTH) and hypophysectomised (HX/ACTH) fetuses received a continuous infusion of ACTH from the time of surgery (115 days gestational age (GA)) at a rate we have previously shown to generate normal fetal cortisol concentrations and term parturition in HX fetuses. A third group of saline-infused intact fetuses (INT/SAL) served as the control group. Adrenal responsiveness was assessed by cortisol responses to ACTH challenges at 120, 130 and 140 days GA.
Introduction
It has long been recognised that parturition in the sheep is dependent upon activation of the fetal hypothalamopituitary-adrenal (HPA) axis (Thorburn & Liggins 1994 ). In the last 2 weeks of gestation there is a characteristic increase in plasma cortisol concentrations which is widely believed to reflect an increase in fetal adrenocorticotrophin (ACTH) concentrations (Challis & Brooks 1989 , Thorburn & Liggins 1994 . The role of ACTH in the timing of parturition was implied by early studies which showed that fetal hypophysectomy (HX) causes adrenal atrophy and prevents delivery (Liggins et al. 1967) , while ACTH infusion at pharmacological doses induces an increase in plasma cortisol levels and premature parturition (Liggins 1968) . Two more recent lines of evidence from our laboratory have, however, led us to question the obligatory role of an increase in fetal ACTH secretion in the initiation of parturition. First, we have demonstrated that labour is not established in fetuses that have undergone hypothalamopituitary disconnection, despite normal or elevated ACTH concentrations and an apparent increase in ACTH concentrations in late gestation (Antolovich et al. 1991 , Ozolins et al. 1992 , Deayton et al. 1994 . Secondly, we have recently shown that HX fetuses continuously infused with a steady-state maintenance dose of ACTH are delivered at normal term with a normal pre-parturient increase in cortisol concentrations ( Jacobs et al. 1994) .
The changing responsiveness of the ovine fetal adrenal gland to ACTH is also believed to contribute to rising cortisol concentrations prior to labour. In vitro and in vivo studies have shown that the fetal adrenal gland becomes increasingly responsive to ACTH stimulation in the last few weeks of gestation (Wintour et al. 1975 , Jones et al. 1977 , Glickman & Challis 1980 , Rose et al. 1982 . Jones & Roebuck (1980) suggested that the ability of the ovine fetal adrenal gland to respond to circulating ACTH in vivo was suppressed by some factor(s), since they found a discrepancy between adrenal cortisol responses to ACTH in vitro and in vivo. In support of this proposal, adrenal cells from 120-day-old fetuses, maintained in an ACTH-free medium, exhibit enhanced responsiveness as the time in culture increases, suggesting the existence of an inhibitor of ACTH action in vivo (Durand et al. 1982) . It has been suggested that these putative inhibitory factors are the high molecular weight (HMW) precursor peptides of ACTH itself, since these peptides have been shown to inhibit ACTH-induced cortisol secretion from adrenal cells in vitro (Roebuck et al. 1980 , Jones et al. 1992 . As the HMW ACTH-containing peptides are present in fetal plasma in high concentrations (Saphier et al. 1993 , Carr et al. 1995 , recent attention has therefore focused on the ratio of low molecular weight (LMW) to HMW ACTH, since it has been proposed that the balance between the stimulatory action of ACTH and the proposed inhibitory action of the HMW ACTH precursor peptides is involved in the regulation of fetal adrenal responsiveness and basal cortisol secretion (Roebuck et al. 1980 , Durand et al. 1982 . It has been speculated that the successful establishment of labour in HX fetuses receiving a constant maintenance infusion of ACTH reflects an enhanced responsiveness of the adrenal glands of these fetuses to ACTH ( Jacobs et al. 1994) .
The present study was undertaken to determine the effect of a constant maintenance ACTH infusion, in fetuses with intact and disrupted hypothalamo-pituitary function, on the timing of labour, basal ACTH and cortisol concentrations and the molecular weight profile of ACTH-containing peptides. In addition, we aimed to formally test the responsiveness of the fetal adrenal gland to an ACTH challenge in ACTH (1-24) -infused intact and HX fetuses.
Materials and Methods

Animals
All procedures involving the use of animals were approved by the Standing Committee on Ethics in Animal Experimentation of Monash University.
Border Leicester-Merino cross-bred ewes of known gestational age (GA) were used in this study. The ewes were housed in individual metabolism cages and fed between 0900 h and 1200 h daily. Water was freely available. Surgery was performed on ewes between 107 days and 119 (115 1) days GA using aseptic techniques. Fetuses underwent HX, as previously described (Mesiano et al. 1987) , or were left intact (INT). Vascular catheters were implanted into a jugular vein and common carotid artery of all fetuses. In most ewes, a maternal jugular vein was catheterised and electromyographic (EMG) electrodes were sutured to the myometrium to record uterine EMG activity for the detection of labour. Fetal well-being was monitored by measuring fetal arterial blood gases using an ABL30 blood gas analyser and OSM2 hemoximeter (Radiometer, Copenhagen, Denmark) . At the end of each experiment, ewes and fetuses were killed by barbiturate overdose (Lethabarb, Arnolds of Reading Pty Ltd, Boronia, Victoria, Australia) administered via the maternal jugular vein catheter.
Experiment 1: gestational outcome, adrenal morphometry and basal hormone concentrations
A total of 28 fetuses was used in this experiment. Eleven fetuses were left intact and received a continuous saline infusion (0·9% NaCl (Baxter Healthcare Pty Ltd, Old Toongabbie, NSW, Australia) containing 50 000 IU heparin/l (Fisons Pty Ltd, Sydney, Australia); 1 ml/h); eight fetuses were left intact and received a continuous maintenance infusion of ACTH (1-24) (Synacthen, Ciba Geigy Australia Ltd, Pendle Hill, NSW, Australia; 43 ng/h per kg estimated fetal body weight) in heparinised saline; and a further nine fetuses underwent HX and also received a continuous maintenance infusion of ACTH in heparinised saline. One of the fetuses in the HX/ACTH group was a twin; both fetuses underwent HX, but only one received the ACTH infusion. Two ewes in the intact saline treated (INT/SAL) group carried twins, and in one of these ewes both twins were studied. All of the INT/ACTH fetuses were singletons. All infusions commenced immediately following surgery. The ACTH infusion rate is exactly the same as that used previously by Jacobs et al. (1994) but in the previous publication the dose was misreported as 100 ng/h per kg. The infusions continued until the end of the study and the dose was increased every 5 days in accordance with the estimated increase in fetal body weight (Cloete 1939) .
The study continued until either the uterine EMG activity indicated the onset of labour or the length of gestation reached 161 days. At post mortem examination, fetal body, adrenal gland and pituitary weights (where present) were recorded. Adrenal glands were fixed in 10% formaldehyde for adrenal morphometry (see below). At post mortem of HX fetuses, the pituitary fossa was examined to ensure completeness of HX. Of at least 50 fetuses that have undergone HX in our laboratory, none has delivered without exogenous stimulation of the adrenal gland (authors' unpublished observations and Mesiano et al. 1987 and Jacobs et al. 1994) .
Routine blood sampling Starting 3 days after surgery, fetal arterial blood samples were collected every 2 or 3 days for the measurement of basal immunoreactive (ir)-ACTH and cortisol concentrations. Blood samples (3 ml) were collected into chilled tubes containing EDTA (5·6 mg in 50 µl; 50 µl/3 ml blood; BDH Chemicals Australia Pty Ltd, Kilsyth, Victoria, Australia). Once every 5 days, blood samples (4 ml) were taken into tubes containing an ACTH degradation inhibitor mix (80 µl; contains aprotinin (1000 kallikrein inhibitor units/ml), N-ethyl-maleimide (25 mg/ml, Sigma Chemical Company, St Louis, MO, USA) and EDTA (18·6 mg/ml, BDH Chemicals) in 0·9% NaCl) for chromatographic analysis of ACTH-containing peptides. All blood samples were centrifuged for 5 min at 3000 r.p.m. at 4 C and the plasma aliquots were stored immediately at 20 C until assayed. ACTH degradation inhibitor mix was added to plasma collected for analysis of ir-ACTH concentration (20 µl/ml plasma). Plasma for ACTH chromatography was acidified with 1·6% glycine in 0·1 M HCl (150 µl/ml plasma).
Experiment 2: the effect of ACTH (1-24) infusion on fetal adrenal responsiveness
A total of 14 fetuses from Experiment 1 was used in these experiments (INT/SAL, n=4; INT/ACTH, n=4; HX/ ACTH, n=6). Commencing at each of 120, 130 and 140 days GA, ACTH was administered to each fetus by rapid intravenous injection at approximately the same time of day (approximately 1500 h). On the first experimental day, 1·0 µg/kg ACTH (1-24) (in 5 ml heparinised saline) was administered, and 24 or 48 h later, 5·0 µg/kg ACTH (1-24) was given. Fetal arterial blood samples (3 ml) were collected at 30 min, 15 min and immediately prior to ACTH injection, and at 10, 30, 60, 90 and 120 min following the injection for analysis of cortisol concentrations. Samples were collected and stored as for routine blood samples (see above). Blood cells were returned to the fetus at the end of the experiment in an equal volume of Hartmann's Solution (Baxter Healthcare).
Adrenal responsiveness for each ACTH (1-24) challenge experiment was measured by integrating the plasma cortisol response to ACTH (1-24) (10-120 min) above the mean pre-injection ( 30 to 0 min) cortisol concentrations. The increase in cortisol concentration was also calculated as an index of adrenal responsiveness and was given by the peak cortisol concentrations achieved following ACTH administration minus the mean preinjection concentrations. It is important to note that this experimental protocol assesses adrenal responsiveness (i.e. the ability of the adrenal gland to produce cortisol in response to given doses of ACTH ) rather than the sensitivity of the adrenal to ACTH (1-24) (i.e. the ED 50 of ACTH in inducing adrenal cortisol production). This approach was taken as it was not feasible to determine full dose-response relationships at each GA and because responsiveness is considered to be the important parameter changed in the pre-partum adrenal gland (Durand et al. 1985) .
Experiment 3: the effect of interrupting the ACTH (1-24) infusion
To assess the contribution of the ACTH infusion to basal ir-ACTH and cortisol concentrations in INT/ ACTH (n=4) and HX/ACTH (n=5) fetuses, the ACTH (1-24) infusion was turned off for a period of 4 h between 132 days and 138 (136 1) days GA. Three HX/ACTH and two INT/ACTH fetuses had been used in Experiment 1, but not Experiment 2, while an additional four fetuses were used solely for this experiment. Fetal arterial blood samples (3 ml) were collected, as for routine blood samples (see above), for ir-ACTH and cortisol radioimmunoassay (RIA; see below), at 30, 15, 0, 15, 30, 45, 60, 120, 180, 240, 255, 270, 285, 300, 330 and 360 min relative to the time when the ACTH (1-24) infusion was turned off. Blood cells were returned to the fetus at regular interval throughout the experiment (see above). Ir-ACTH concentrations were measured using the ICN RIA (see below).
General methods
Adrenal morphometry Following fixation, the adrenal glands from a subset of fetuses in Experiment 1 were embedded in paraffin wax and sectioned (10 µm), transverse to the long axis, in the mid-glandular region. Sections were stained with haematoxylin and eosin for examination by light microscopy. A magnetic optical plate (Cadmate, CM-1212A, SDR Clinical Technology, Middle Cove, NSW, Australia) interfaced with a personal computer was used to measure the areas represented by the adrenal cortex and the whole adrenal. Results from six sections from each animal were averaged.
Chromatographic analysis of ACTH-containing peptides
To separate ir-ACTH species of differing MW, plasma samples (1 ml) collected for chromatographic analysis (Experiment 1) were individually thawed and loaded onto a Sephadex G50 Fine gel filtration chromatography column (Pharmacia LKB, Uppsala, Sweden), as previously described (Hollingworth et al. 1995) . The sample was eluted with 1% formic acid containing 1 g/l Polypep (Sigma) at a rate of 10 ml/h. Fractions (2 ml) were collected, lyophilised in a rotary evaporator and stored at 20 C. Lyophilised fractions were reconstituted in assay buffer (0·3 ml) and left at room temperature for approximately 2 h prior to assay for ir-ACTH concentration using the Monash RIA (see below). HMW and LMW ir-ACTH concentrations in each sample were calculated as the sum of ir-ACTH concentrations in fractions 8-11 and the sum of ir-ACTH concentrations in fractions 14-16 respectively. LMW ir-ACTH concentrations were expressed as a percentage of total ir-ACTH (i.e. the sum of LMW and HMW ir-ACTH concentrations).
Radioimmunoassays Fetal plasma cortisol concentrations were measured by RIA after extraction with dichloromethane, as previously described (Bocking et al. 1986 ). The intra-and inter-assay coefficients of variation were 5 and 18% respectively, at a value of 12·8 0·5 ng/ ml. The sensitivity of the assay was 1·2 0·3 ng/ml. The average recovery for the cortisol extraction procedure was 95 1%. Ir-ACTH concentrations in chromatographic fractions and unextracted fetal plasma were measured in an RIA established at Monash University for these purposes (Hollingworth et al. 1995) . The intra-and inter-assay coefficients of variation for the Monash RIA were 7 and 20% respectively, at a value of 1518·8 65·5 pg/ml. The sensitivity of the assay was 16·8 4·1 pg/ml. Ir-ACTH concentrations in selected samples of unextracted fetal plasma were also measured using a commercially available RIA kit (ICN Biomedicals Australasia Pty Ltd, Seven Hills, NSW, Australia). The intra-and inter-assay coefficients of variation for the ICN RIA were 10 and 7% respectively, at a value of 147·0 4·4 pg/ml. The sensitivity of this assay was 8·5 1·0 pg/ml. Both of these ACTH antisera cross react with peptides containing the ACTH sequence, including the HMW precursor peptides of ACTH. There was a significant (P<0·001) correlation between ir-ACTH concentrations in the same plasma samples when measured using each of these ACTH RIAs. The regression equation in the analysis was: y=1·3x+123 where y=[ir-ACTH] (pg/ml) using the Monash RIA and x=[ir-ACTH] (pg/ml) using the ICN RIA (n=104, r=0·71).
Statistics All results are expressed as means standard error of the mean (...). Data were first tested for homogeneity of variance using Bartlett-Box F and Cochran's C tests. Data found heterogeneous were rendered homogeneous by square root or logarithmic transformation. The effects of experimental group, GA, time and individual animals were tested using multifactorial ANOVA for repeated measures. Where appropriate, least significant difference (LSD) tests were applied to identify differences between means. Statistical significance is reported at the 0·05 level.
Results
Experiment 1: gestational outcome and basal hormone concentrations
Fetal outcome One ewe in the HX/ACTH group did not show any signs of labour by 161 days GA, at which time she and the fetus were killed. The fetus of another ewe in this group died at 151 days GA (due to an intrauterine infection) before any signs of labour. Results from these fetuses were excluded from analyses of basal hormone concentrations since the day of labour onset could not be determined and hence results could not be adjusted to the day of labour. All other ewes had apparently normal labour.
The mean gestation lengths, fetal body weights, combined fetal adrenal weights, adrenal/body weight ratios and the ratio of the adrenal cortex to the total adrenal area at term for each group of fetuses (from ewes that went into labour) are shown in Table 1 . There were no significant differences in gestation lengths between the three groups of fetuses. Body weights at term in INT/ACTH and HX/ACTH fetuses were significantly reduced compared with those in INT/SAL fetuses. There were no significant differences in adrenal weights between the three groups of fetuses and the mean adrenal/body weight ratios at term were not significantly different between the three groups. The adrenal/body weight ratio of the HX/ACTH fetus that failed to deliver by 161 days GA was 0·08. This is substantially less than those of HX/ACTH fetuses that delivered (mean 0·15, 95% confidence limits 0·13-0·17, see Table 1 ), and is similar to that of untreated HX fetuses killed at 147 days (Mesiano et al. 1987 ). There were no significant differences in the ratios of the areas of the adrenal cortex to the total adrenal area at term between the three groups of fetuses.
Basal cortisol concentrations There were no significant differences in basal cortisol concentrations between the three groups of fetuses over the last 28 days of gestation (Fig. 1A) . In all groups of fetuses, there was a significant increase in cortisol concentrations with advancing GA which first reached statistical significance, as determined by LSD test, 14 days before labour (when compared with the first three GA points). In the HX/ACTH fetus that did not deliver, basal cortisol concentrations rose to 80 ng/ml at 155 days GA, but then fell dramatically to 10 ng/ml by 161 days GA, while in the HX/ACTH fetus that suffered an intrauterine death at 151 days, fetal cortisol concentrations were increasing until the time of death.
Basal ir-ACTH concentrations
Monash RIA There were no significant differences in basal plasma ir-ACTH concentrations as measured by the Monash RIA between the three groups of fetuses (Fig. 1B) . In both INT/SAL and INT/ACTH fetuses, there were significant increases in ir-ACTH concentrations in the last 4 days of gestation (when compared with the first three time points, as determined by LSD test). In HX/ACTH fetuses, however, at no time point could the ir-ACTH concentrations be identified as significantly different from control values (the first three time points) by LSD test, indicating no significant increase in ir-ACTH concentrations prior to labour. The ir-ACTH concentrations in the HX/ACTH fetuses that did not deliver, or suffered an intrauterine death, were not substantially different from other fetuses in this group.
ICN RIA As the results obtained using the Monash RIA suggested that increases in ir-ACTH concentrations did not occur in the HX/ACTH fetuses, we wished to confirm this observation by using a completely independent assay. Accordingly, ir-ACTH concentrations were assessed in selected plasma samples using a commercially available ACTH RIA (ICN RIA kit). Since not all samples were available for assay, the study period was divided into six GA blocks, each 5 days in length, and one sample per block (the latest in GA possible) per animal was assayed (Table 2 ). For comparison, results obtained using the Monash RIA for all samples within each of these GA blocks (two or three samples) were averaged and are also presented in Table 2 . There were no significant differences in basal plasma ir-ACTH concentrations as measured using the ICN RIA between the three groups of fetuses. In both INT/SAL and INT/ACTH fetuses, there were significant increases in basal ir-ACTH concentrations (when compared with the first two GA blocks, as determined by LSD test) in the last 9 days of gestation. In contrast, there were no significant changes in basal ir-ACTH concentrations with advancing GA in HX/ACTH fetuses. Analysis of ir-ACTH concentrations as measured using the Monash RIA and presented in this format revealed the same pattern of results; i.e. no effect of experimental group and significant increases in ir-ACTH concentrations with advancing GA in INT/SAL and INT/ACTH fetuses but not HX/ACTH fetuses.
Percentage of LMW ir-ACTH in plasma samples
Since samples for the assessment of LMW ir-ACTH were taken every 5 days, data obtained for the percentage of LMW ir-ACTH as a proportion of total ir-ACTH are presented in six GA blocks, each 5 days in length (as described above for ir-ACTH concentrations). There was a significant effect of treatment group on the percentage of LMW ir-ACTH (Fig. 2) . The percentage of LMW ir-ACTH in plasma from INT/ACTH fetuses was significantly greater than that in INT/SAL fetuses, while the percentage of LMW ir-ACTH in plasma from HX/ ACTH fetuses was intermediate between, and not different from, that of INT/SAL and INT/ACTH fetuses. In plasma from INT/SAL fetuses, there was a significant increase in the percentage of LMW ir-ACTH in the last 4 days of gestation (when compared with the first two GA blocks). There were no significant changes in the percentage of LMW ir-ACTH with advancing GA in plasma from INT/ACTH or HX/ACTH fetuses.
Experiment 2: the effect of ACTH (1-24) infusion on fetal adrenal responsiveness
Adrenal responsiveness was assessed by measuring both the area under the cortisol response curve (Fig. 3 ) and the increase in cortisol concentrations achieved (Table 3) following the administration of 1·0 µg/kg and 5·0 µg/kg ACTH to INT/SAL, INT/ACTH and HX/ACTH fetuses at 120, 130 and 140 days GA. Identical statistical conclusions were drawn from the assessment of both indices of adrenal responsiveness, and for clarity in the following description the term adrenal responsiveness encompasses both area under the cortisol response curve and the increase in cortisol concentrations achieved. It is of note that the HX/ACTH fetus that did not deliver, and that which suffered an intrauterine death, responded to the exogenous ACTH (1-24) so their results have been included in the group data for the HX/ACTH fetuses. There was a significant effect of treatment on adrenal responsiveness. Adrenal responsiveness was significantly greater in both groups receiving ACTH (1-24) infusion (i.e. INT/ACTH and HX/ACTH fetuses) than in INT/SAL fetuses. There was no significant difference in adrenal responsiveness between INT/ACTH and HX/ACTH fetuses. In all groups of fetuses, adrenal responsiveness significantly increased with advancing GA, and there was a significant effect of ACTH challenge dose on adrenal responsiveness. There were no significant differences in basal cortisol concentrations prior to each ACTH (1-24) challenge experiment (each ACTH dose) at any GA, in any group of fetuses (data not shown). The mean area under the cortisol response curve (for all GAs) in INT/SAL fetuses was 481 117 ng.min per ml, (n=6) and HX/ACTH (n=7) fetuses (only those from ewes that went into labour). There were no significant differences in basal cortisol concentrations between the three groups of fetuses. In all groups of fetuses, there was a significant increase in cortisol concentrations with advancing GA. There were no significant differences in basal ir-ACTH concentrations between the three groups of fetuses. There were significant increases in ir-ACTH concentrations in INT/SAL and INT/ACTH fetuses but not HX/ACTH fetuses. Asterisks indicate values, for each hormone, that are significantly different (from the first three GA points) as indicated by LSD test.
in INT/ACTH fetuses 3478 472 ng.min per ml and in HX/ACTH fetuses 2423 277 ng.min per ml. The mean increase in cortisol concentrations achieved (for all GAs) in INT/SAL fetuses was 8·1 1·3 ng/ml, in INT/ACTH fetuses was 43·4 5·2 ng/ml, and HX/ACTH fetuses was 29·6 3·1 ng/ml. It should be noted that there exists the same rank order for the percentage of LMW ir-ACTH, adrenal responsiveness and the increase in cortisol concentrations, i.e. INT/SAL<HX/ACTH<INT/ACTH.
Experiment 3: effect of interrupting the ACTH (1-24) infusion
The effects on ir-ACTH and cortisol concentrations in INT/ACTH and HX/ACTH fetuses of stopping the maintenance ACTH infusion for 4 h are presented in Table 2 Plasma ir-ACTH concentrations (pg/ml) from 29-25 days before labour (DBL) to 5-0 days before labour in INT/SAL (n=7), INT/ACTH (n=6) and HX/ACTH (n=7) There was a significant difference in adrenal responsiveness between the three groups of fetuses. Adrenal responsiveness in INT/ACTH and HX/ACTH fetuses was significantly greater than that in INT/SAL fetuses; however, there was no significant difference in adrenal responsiveness between INT/ACTH and HX/ACTH fetuses. There was a significant increase in adrenal responsiveness with advancing GA in all groups of fetuses. Different letters indicate GAs that were significantly different from each other within each treatment group. -24) infusion. In INT/ACTH fetuses, there was no significant difference in ir-ACTH concentrations as a result of interrupting the ACTH infusion. Cortisol concentrations in INT/ACTH fetuses were significantly lower during the interruption of the infusion than after its recommencement, though the values obtained prior to the interruption were not significantly different to any other time period. In HX/ACTH fetuses, the interruption of the ACTH (124) infusion led to a significant decrease in both ir-ACTH and cortisol concentrations. The recommencement of the ACTH infusion restored the concentrations of both hormones in these fetuses.
Discussion
The central finding of this study is that term parturition can occur in both intact and HX fetuses provided with a constant, maintenance infusion of ACTH . This result confirms and extends the finding of Jacobs et al. (1994) that this infusion of ACTH is sufficient to permit the maturation of the fetal adrenal cortex and the onset of labour at the expected time in HX fetuses. In addition, we have demonstrated that the same ACTH infusion regimen in intact fetuses is not sufficient to significantly advance parturition or adrenal maturation. Labour in all groups of fetuses in this study was characterised by an increase in plasma cortisol concentrations beginning around 14 days before term, as shown previously (Bassett & Thorburn 1969 , Jacobs et al. 1994 , but this was not associated with an increase in plasma ir-ACTH concentrations in ACTH (1-24) -infused HX fetuses. This observation was confirmed by assaying ir-ACTH concentrations in two distinct RIAs, thus reinforcing the biological conclusions which may be drawn from the data. In contrast to HX/ACTH fetuses, increases in ir-ACTH concentrations were observed using both RIAs in both saline-and ACTH (1-24) -infused intact fetuses. Thus, a late gestation increase in fetal ir-ACTH concentrations appears not to be an absolute prerequisite for parturition in the sheep. Adrenal cortical growth, as assessed morphometrically, and adrenal maturation, reflected in basal cortisol concentrations, were similar in all groups of fetuses. It has previously been suggested that HMW ACTH-containing peptides antagonise the steroidogenic effect of LMW ACTH on the fetal adrenal and that the ratio of HMW to LMW ACTH-containing peptides is an important Different letters indicate treatment groups (x, y) or GAs (within each treatment group: a-c) that are significantly different from each other as indicated by LSD test. Asterisk indicate GAs at which a signficant difference between the two doses of ACTH was identified by LSD test.
